These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 14689374

  • 1. Improving the bacteriological safety of platelet transfusions.
    Blajchman MA, Goldman M, Baeza F.
    Transfus Med Rev; 2004 Jan; 18(1):11-24. PubMed ID: 14689374
    [Abstract] [Full Text] [Related]

  • 2. Pathogen-reduced platelets for the prevention of bleeding.
    Butler C, Doree C, Estcourt LJ, Trivella M, Hopewell S, Brunskill SJ, Stanworth S, Murphy MF.
    Cochrane Database Syst Rev; 2013 Mar 28; (3):CD009072. PubMed ID: 23543569
    [Abstract] [Full Text] [Related]

  • 3. Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine.
    Hillyer CD, Josephson CD, Blajchman MA, Vostal JG, Epstein JS, Goodman JL.
    Hematology Am Soc Hematol Educ Program; 2003 Mar 28; ():575-89. PubMed ID: 14633800
    [Abstract] [Full Text] [Related]

  • 4. Bacterial contamination of platelet components: potential solutions to prevent transfusion-related sepsis.
    Corash L.
    Expert Rev Hematol; 2011 Oct 28; 4(5):509-25. PubMed ID: 21939419
    [Abstract] [Full Text] [Related]

  • 5. Improving the bacteriological safety of platelet transfusions.
    Cid J, Lozano M.
    Transfus Med Rev; 2004 Jul 28; 18(3):235-6; author reply 236. PubMed ID: 15248173
    [No Abstract] [Full Text] [Related]

  • 6. Bacterial contamination of platelets for transfusion: strategies for prevention.
    Levy JH, Neal MD, Herman JH.
    Crit Care; 2018 Oct 27; 22(1):271. PubMed ID: 30367640
    [Abstract] [Full Text] [Related]

  • 7. Bacterial detection of platelets: current problems and possible resolutions.
    Blajchman MA, Beckers EA, Dickmeiss E, Lin L, Moore G, Muylle L.
    Transfus Med Rev; 2005 Oct 27; 19(4):259-72. PubMed ID: 16214015
    [Abstract] [Full Text] [Related]

  • 8. Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction.
    Kerkhoffs JL, van Putten WL, Novotny VM, Te Boekhorst PA, Schipperus MR, Zwaginga JJ, van Pampus LC, de Greef GE, Luten M, Huijgens PC, Brand A, van Rhenen DJ, Dutch - Belgian HOVON cooperative group.
    Br J Haematol; 2010 Jul 27; 150(2):209-17. PubMed ID: 20507310
    [Abstract] [Full Text] [Related]

  • 9. Improving platelet safety: bacterial contamination of platelets.
    Brecher ME, Hay SN.
    Curr Hematol Rep; 2004 Mar 27; 3(2):121-7. PubMed ID: 14965488
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bacterial contamination of blood components: Norwegian strategies in identifying donors with higher risk of inducing septic transfusion reactions in recipients.
    Klausen SS, Hervig T, Seghatchian J, Reikvam H.
    Transfus Apher Sci; 2014 Oct 27; 51(2):97-102. PubMed ID: 25242310
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Amotosalen: Allogeneic Cellular Immunotherapies system, INTERCEPT Plasma System, INTERCEPT Platelet System, S 59.
    BioDrugs; 2003 Oct 27; 17(1):66-8. PubMed ID: 12534321
    [Abstract] [Full Text] [Related]

  • 15. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial.
    van Rhenen D, Gulliksson H, Cazenave JP, Pamphilon D, Ljungman P, Klüter H, Vermeij H, Kappers-Klunne M, de Greef G, Laforet M, Lioure B, Davis K, Marblie S, Mayaudon V, Flament J, Conlan M, Lin L, Metzel P, Buchholz D, Corash L, euroSPRITE trial.
    Blood; 2003 Mar 15; 101(6):2426-33. PubMed ID: 12456508
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of the post-transfusion platelet increment and safety of riboflavin-based pathogen reduction technology (PRT) treated platelet products stored in platelet additive solution for 5 days or less versus 6-7 days.
    Kaplan A, Lindgren B, Marschner S, Aznar M, Zalba S, Sánchez P, Ayape ML, Olavarría E, Antelo ML.
    Transfus Apher Sci; 2016 Apr 15; 54(2):248-52. PubMed ID: 26345109
    [Abstract] [Full Text] [Related]

  • 18. Bacterial contamination of platelet concentrates: incidence, significance, and prevention.
    Blajchman MA, Goldman M.
    Semin Hematol; 2001 Oct 15; 38(4 Suppl 11):20-6. PubMed ID: 11727282
    [Abstract] [Full Text] [Related]

  • 19. A multi-centre study of therapeutic efficacy and safety of platelet components treated with amotosalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion.
    Lozano M, Knutson F, Tardivel R, Cid J, Maymó RM, Löf H, Roddie H, Pelly J, Docherty A, Sherman C, Lin L, Propst M, Corash L, Prowse C.
    Br J Haematol; 2011 May 15; 153(3):393-401. PubMed ID: 21418180
    [Abstract] [Full Text] [Related]

  • 20. Reducing the risk of bacterial contamination of cellular blood components.
    Blajchman MA.
    Dev Biol (Basel); 2000 May 15; 102():183-93. PubMed ID: 10794105
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.